Related Experiment Video
Updated: Aug 20, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological
Damien D Pearse1, Francisco C Pereira, Anna Stolyarova
1The Miami Project to Cure Paralysis, University of Miami School of Medicine, PO Box 016960 (R-48), Miami, FL 33101, USA. DPearse@miamiproject.med.miami.edu
Abstract:
Microglia respond in a stereotypical pattern to a diverse array of pathological states. These changes are coupled to morphological and immunophenotypical alterations and the release of a variety of reactive species, trophic factors and cytokines that modify both microglia and their cellular environment. We examined whether a microglial-produced cytokine, tumour necrosis factor-alpha (TNF-alpha), was involved in the maintenance of microglial activation after spinal cord injury by selective inhibition using TNF-alpha antisense deoxyoligonucleotides (ASOs). Microglia and macrophages harvested from 3 d post-contused rat spinal cord were large and rounded (86.3 +/- 9.6%). They were GSA-IB4-positive (GSA-IB4(+)) (Griffonia simplicifolia lectin, microglia specific; 94.8 +/- 5.1%), strongly OX-42 positive (raised against a type 3 complement/integrin receptor, CD11b; 78.9 +/- 9.1%), ED-1 positive (a lysosomal marker shown to correlate well with immune cell activation; 97.2 +/- 2.6%) and IIA positive (antibody recognizes major histocompatibility complex II; 57.2 +/- 5.6%), indicative of fully activated cells, for up to 48 h after plating. These cells also secreted significant amounts of TNF-alpha (up to 436 pg/microg total protein, 16 h). Fluoroscein isothiocyanate-labelled TNF-alpha ASOs (5, 50 and 200 nm) added to the culture medium were taken up very efficiently into the cells (> 90% cells) and significantly reduced TNF-alpha production by up to 92% (26.5 pg/microg total protein, 16 h, 200 nm TNF-alpha ASOs). Furthermore, few of the treated cells at this time were round (5.4 +/- 2.7%), having become predominantly spindle shaped (74.9 +/- 6.3%) or stellate (21.4 +/- 2.7%); immunophenotypically, although all of them remained GSA-IB4 positive (91.6 +/- 6.2%), many were weakly OX-42 positive and few expressed either ED-1 (12.9 +/- 2.5%) or IIA (19.8 +/- 7.4%). Thus, the secretion of TNF-alpha early in spinal cord injury may be involved in autoactivating microglia/macrophages. However, at the peak of microglial activation after injury, the activation state of microglia/macrophages is not stable and this process may still be reversible by blocking TNF-alpha.
Insights
Tumor necrosis factor-alpha (TNF-alpha) contributes to sustained microglial activation following spinal cord injury. Blocking TNF-alpha with antisense deoxyoligonucleotides (ASOs) reversed microglial activation, suggesting a potential therapeutic target.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia exhibit stereotypical responses to pathology, involving morphological and immunophenotypical changes.
- These activated microglia release factors that modify their environment and potentially sustain their activation state.
Purpose of the Study:
- To investigate the role of microglial-produced tumor necrosis factor-alpha (TNF-alpha) in maintaining microglial activation post-spinal cord injury.
- To assess the efficacy of selective TNF-alpha inhibition using antisense deoxyoligonucleotides (ASOs) in modulating microglial activation.
Main Methods:
- Microglia and macrophages were isolated from contused rat spinal cords.
- Cells were characterized morphologically and immunophenotypically (GSA-IB4, OX-42, ED-1, IIA).
- TNF-alpha production was measured, and the effects of TNF-alpha ASOs on cell activation and morphology were evaluated.
Main Results:
- Activated microglia/macrophages from injured spinal cords exhibited rounded morphology and expressed high levels of GSA-IB4, OX-42, ED-1, and IIA.
- These cells secreted significant amounts of TNF-alpha.
- Treatment with TNF-alpha ASOs efficiently reduced TNF-alpha production and induced a shift in cell morphology towards spindle and stellate shapes.
- ASO treatment also led to decreased expression of ED-1 and IIA markers, indicating reduced activation.
Conclusions:
- Early TNF-alpha secretion by microglia/macrophages may contribute to their autoactivation after spinal cord injury.
- Microglial/macrophage activation at the peak of injury is not a stable state and can be reversed by blocking TNF-alpha.
- Targeting TNF-alpha represents a potential strategy for modulating microglial responses in spinal cord injury.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019